Bevacizumab ( 貝伐珠單抗 )
產(chǎn)品名稱： Bevacizumab ( 貝伐珠單抗 )
英文名稱：
產(chǎn)品編號(hào)： FrdE00012
產(chǎn)品價(jià)格： null
產(chǎn)品產(chǎn)地： 中國(guó)
品牌商標(biāo)： Frdbio
更新時(shí)間： 2023-08-15T17:03:56
使用范圍：
- 聯(lián)系人 : 趙經(jīng)理
- 地址 : 光谷國(guó)際B座1513
- 郵編 :
- 所在區(qū)域 : 湖北省
- 電話 : 158****4543 點(diǎn)擊查看
- 傳真 : 點(diǎn)擊查看
- 郵箱 : 2633787800@qq.com
- 二維碼 : 點(diǎn)擊查看
Product name:Bevacizumab (?貝伐珠單抗?)
Catalog No. :?FrdE00012
MW:149000.00 Da
Description:Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab, a humanized monoclonal antibody,specifically binds to all VEGF-A isoforms with high affinity.
Alternative names:Bevacizumab
Specificity target name;species:VEGFA[Homo sapiens]
Form:?Liquid
Receptor identification:IgG1-kappa
Storage:?Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 °C for frequent use. Store at -20 to -80 °C for twelve months from the date of receipt.
Purity:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Note:?This product is for research use only,not for diagnostic or therapeutic use.